Type 1 interferonopathy

MONDO:0700264

Conditions in which increased type 1 interferon signaling leads to autoimmune and neurological disorders. These disorders are caused by variants in genes involved in nucleic acid metabolism, sensing, and the innate immune response.

57 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Broader categories

Sort by